tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
Advertisement

Summit Therapeutics (SMMT) Similar Stocks

Compare
1,694 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$21.43
$15.50B
15.15%
11 Buy
1 Hold
3 Sell
Moderate Buy
Incyte
$86.85
$16.96B
19.74
29.55%
8 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$453.07
$19.82B
17.31
29.42%
9 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$204.05
$12.36B
43.02%
16 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$33.56
$19.20B
15.91
43.42%
5 Buy
1 Hold
1 Sell
Moderate Buy
BioNTech SE
$105.49
$25.12B
-14.01%
12 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
21.43
2.51
13.27%
INCY
Incyte
86.85
21.09
32.07%
UTHR
United Therapeutics
453.07
103.22
29.50%
ASND
Ascendis Pharma
204.05
64.91
46.65%
GMAB
Genmab
33.56
10.13
43.24%
BNTX
BioNTech SE
105.49
-16.06
-13.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis